Evidence map›Paper›PMID 41097357›Full record

ArticleMolecules (Basel, Switzerland)2025

Fate of Tebuconazole and Trifloxystrobin in Edible Rose Petals: Storage Stability and Human Health Risk Assessment.

Xiaotong Qin, Jinwei Zhang, Yan Tao, Li Chen, Pingzhong Yu, Junjie Jing, Ercheng Zhao, Yongquan Zheng, Min He

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaotong QinInstitute of Plant Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100097, China.
Jinwei ZhangInstitute of Plant Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100097, China.
Yan TaoInstitute of Plant Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100097, China.
Li ChenInstitute of Plant Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100097, China.
Pingzhong YuInstitute of Plant Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100097, China.
Junjie JingInstitute of Plant Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100097, China.
Ercheng ZhaoInstitute of Plant Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100097, China.
Yongquan ZhengCollege of Plant Health and Medicine, Qingdao Agricultural University, Qingdao 266109, China.
Min HeInstitute of Plant Protection, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100097, China.ORCID 0000-0002-6115-0294

Funding

the National Key R&D Program of China 2022YFD1401200，2023YFD1701300
6 · The paper itself

Abstract

This study addresses the absence of maximum residue limits (MRLs) for tebuconazole and trifloxystrobin in edible rose petals in China by systematically evaluating the residue behavior and dietary exposure risks of these fungicides. An analytical method based on QuEChERS sample preparation coupled with UPLC-MS/MS was developed for the simultaneous determination of tebuconazole, trifloxystrobin, and its metabolite CGA321113 in fresh and dried rose petals. Field trials under the highest application conditions (184 g a.i./hm

Indexed as

AcetatesFlowersFungicides, IndustrialIminesPesticide ResiduesRosaStrobilurinsTriazolesFood ContaminationHumansRisk AssessmentTandem Mass SpectrometryAcetatesFungicides, IndustrialIminesPesticide ResiduesStrobilurinstebuconazoleTriazolestrifloxystrobinedible rose petalspesticide residuerisk assessmenttebuconazoletrifloxystrobin

Identifiers

PMID41097357
PMCPMC12525913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.